BIOMAT Database Logo BIOMAT Database Logo

[Studies of the action of glucagon on phases of ventricular systole and excito-conducting function of the heart in patients with cardiac insufficiency]. 1972

V Tacu, and M Casetti, and S Rucinski, and M Platon

UI MeSH Term Description Entries
D006973 Hypertension Persistently high systemic arterial BLOOD PRESSURE. Based on multiple readings (BLOOD PRESSURE DETERMINATION), hypertension is currently defined as when SYSTOLIC PRESSURE is consistently greater than 140 mm Hg or when DIASTOLIC PRESSURE is consistently 90 mm Hg or more. Blood Pressure, High,Blood Pressures, High,High Blood Pressure,High Blood Pressures
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D011660 Pulmonary Heart Disease Hypertrophy and dilation of the RIGHT VENTRICLE of the heart that is caused by PULMONARY HYPERTENSION. This condition is often associated with pulmonary parenchymal or vascular diseases, such as CHRONIC OBSTRUCTIVE PULMONARY DISEASE and PULMONARY EMBOLISM. Cor Pulmonale,Disease, Pulmonary Heart,Diseases, Pulmonary Heart,Heart Disease, Pulmonary,Heart Diseases, Pulmonary,Pulmonary Heart Diseases
D003327 Coronary Disease An imbalance between myocardial functional requirements and the capacity of the CORONARY VESSELS to supply sufficient blood flow. It is a form of MYOCARDIAL ISCHEMIA (insufficient blood supply to the heart muscle) caused by a decreased capacity of the coronary vessels. Coronary Heart Disease,Coronary Diseases,Coronary Heart Diseases,Disease, Coronary,Disease, Coronary Heart,Diseases, Coronary,Diseases, Coronary Heart,Heart Disease, Coronary,Heart Diseases, Coronary
D005260 Female Females
D005934 Glucagon A 29-amino acid pancreatic peptide derived from proglucagon which is also the precursor of intestinal GLUCAGON-LIKE PEPTIDES. Glucagon is secreted by PANCREATIC ALPHA CELLS and plays an important role in regulation of BLOOD GLUCOSE concentration, ketone metabolism, and several other biochemical and physiological processes. (From Gilman et al., Goodman and Gilman's The Pharmacological Basis of Therapeutics, 9th ed, p1511) Glucagon (1-29),Glukagon,HG-Factor,Hyperglycemic-Glycogenolytic Factor,Proglucagon (33-61),HG Factor,Hyperglycemic Glycogenolytic Factor
D006329 Heart Conduction System An impulse-conducting system composed of modified cardiac muscle, having the power of spontaneous rhythmicity and conduction more highly developed than the rest of the heart. Conduction System, Heart,Conduction Systems, Heart,Heart Conduction Systems,System, Heart Conduction,Systems, Heart Conduction
D006333 Heart Failure A heterogeneous condition in which the heart is unable to pump out sufficient blood to meet the metabolic need of the body. Heart failure can be caused by structural defects, functional abnormalities (VENTRICULAR DYSFUNCTION), or a sudden overload beyond its capacity. Chronic heart failure is more common than acute heart failure which results from sudden insult to cardiac function, such as MYOCARDIAL INFARCTION. Cardiac Failure,Heart Decompensation,Congestive Heart Failure,Heart Failure, Congestive,Heart Failure, Left-Sided,Heart Failure, Right-Sided,Left-Sided Heart Failure,Myocardial Failure,Right-Sided Heart Failure,Decompensation, Heart,Heart Failure, Left Sided,Heart Failure, Right Sided,Left Sided Heart Failure,Right Sided Heart Failure
D006339 Heart Rate The number of times the HEART VENTRICLES contract per unit of time, usually per minute. Cardiac Rate,Chronotropism, Cardiac,Heart Rate Control,Heartbeat,Pulse Rate,Cardiac Chronotropy,Cardiac Chronotropism,Cardiac Rates,Chronotropy, Cardiac,Control, Heart Rate,Heart Rates,Heartbeats,Pulse Rates,Rate Control, Heart,Rate, Cardiac,Rate, Heart,Rate, Pulse

Related Publications

V Tacu, and M Casetti, and S Rucinski, and M Platon
[The temporal behavior of heart action phases in cardiac insufficiency with tachycardiac flutter arrhythmia. (Statistical studies)].
July 1959, Zeitschrift fur Kreislaufforschung,
V Tacu, and M Casetti, and S Rucinski, and M Platon
[Effect of coenzymes on the systole-diastolic function of the myocardium in patients with cardiac insufficiency].
January 1973, Terapevticheskii arkhiv,
V Tacu, and M Casetti, and S Rucinski, and M Platon
[EFFECT OF STROPHANTHIN AND DIGITOXIN ON THE ACTION PHASES OF THE HEART IN CARDIAC INSUFFICIENCY].
February 1965, Die Medizinische Welt,
V Tacu, and M Casetti, and S Rucinski, and M Platon
[Cardiac action of glucagon in patients with heart diseases].
July 1971, Prensa medica argentina,
V Tacu, and M Casetti, and S Rucinski, and M Platon
[The significance of cardiac systole phases in the diagnosis of left ventricular aneurysm].
January 1981, Vojnosanitetski pregled,
V Tacu, and M Casetti, and S Rucinski, and M Platon
[Effects of proscillaridin A on the duration of phases of ventricular systole and on normal heart rate].
December 1965, Rivista critica di clinica medica,
V Tacu, and M Casetti, and S Rucinski, and M Platon
Duration of the phases of left ventricular systole.
June 1963, Circulation research,
V Tacu, and M Casetti, and S Rucinski, and M Platon
[On the relations between the phases of the right ventricular systole and the pulmonary hemodynamic regime. I. On the duration of phases of the right ventricular systole: its relation to endoventricular pressure and cardiac rate].
December 1960, Minerva cardioangiologica,
V Tacu, and M Casetti, and S Rucinski, and M Platon
[THE DURATION OF INDIVIDUAL PHASES OF CARDIAC SYSTOLE IN PATIENTS WITH CHRONIC LUNG DISEASES].
August 1964, Terapevticheskii arkhiv,
V Tacu, and M Casetti, and S Rucinski, and M Platon
[Effect of glucagon on the hemodynamics in patients with and without heart insufficiency].
January 1970, Verhandlungen der Deutschen Gesellschaft fur Kreislaufforschung,
Copied contents to your clipboard!